Real-world treatment outcomes among Veterans prescribed PARPis for Prostate cancer and to compare outcomes between patients with BRCA2 gene variants and those with variants in other homologous DNA repair genes
Latest Information Update: 30 Jul 2021
At a glance
- Drugs Niraparib (Primary) ; Olaparib (Primary) ; Rucaparib (Primary) ; Talazoparib (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology